Services
Multimodal Imaging & Biomarker Integration
Connecting Molecular Signals to Clinical Meaning
ZRO integrates PET and MRI with plasma- and CSF-based biomarkers to build a unified view of neurodegenerative disease.By linking molecular pathology to brain structure, function, and clinical progression, we help sponsors understand therapeutic mechanisms and quantify biological impact.
Cross-Modal Insight
Our multimodal programs combine imaging endpoints with fluid biomarkers to support early discovery, diagnostic validation, and longitudinal monitoring.
This integrated approach accelerates biomarker qualification and enables targeted evidence generation for scientific interpretation and publication.
Key Capabilities
Our multimodal programs combine imaging endpoints with fluid biomarkers to support early discovery, diagnostic validation, and longitudinal monitoring.
This integrated approach accelerates biomarker qualification and enables targeted evidence generation for scientific interpretation and publication.
- Integrated study design combining multimodal imaging and fluid biomarkers
- Harmonized imaging and assay workflows
- Quantitative analysis and evidence generation to address specific scientific questions
-
Translational bridge between preclinical and clinical research
Why Sponsors Choose ZRO
We connect imaging science and biomarker innovation within a single, rigorous framework.
The result: multimodal evidence that supports faster, more confident decisions in drug and diagnostic development.